Impact of Interferon Alfa-2b and Ribavirin on Progression of Liver Fibrosis in Patients With Chronic Hepatitis C

Alter, 1997, Hepatology, 26, 62, 10.1002/hep.510260711 WHO, 1997, Wkly Epidemiol Rec, 72, 341 Poynard, 1997, for the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet, 349, 825 Seeff, 1992, N Engl J Med, 327, 1906, 10.1056/NEJM199212313272703 Tong, 1995, N Engl J Med, 332, 1463, 10.1056/NEJM199506013322202 Darby, 1997, Lancet, 350, 1425, 10.1016/S0140-6736(97)05413-5 Poynard, 1996, Hepatology, 24, 778, 10.1002/hep.510240405 Camma, 1997, J Hepatol, 26, 1187, 10.1016/S0168-8278(97)80451-5 Reichard, 1998, Lancet, 351, 83, 10.1016/S0140-6736(97)06088-1 Poynard, 1998, Lancet, 352, 1426, 10.1016/S0140-6736(98)07124-4 McHutshison, 1998, N Engl J Med, 339, 1485, 10.1056/NEJM199811193392101 Davis, 1998, N Engl J Med, 339, 1493, 10.1056/NEJM199811193392102 Sobesky, 1999, Gastroenterology, 116, 378, 10.1016/S0016-5085(99)70135-6 Pilette, 1997, Gastroenterol Clin Biol, 21, 466 Patterson, 1990, Rev Infect Dis, 12, 1332 Ning, 1998, J Immunol, 160, 3487, 10.4049/jimmunol.160.7.3487 Knodell, 1981, Hepatology, 1, 431, 10.1002/hep.1840010511 The METAVIR cooperative group., 1994, Hepatology, 20, 15, 10.1002/hep.1840200104 Bedossa, 1996, for the French METAVIR group Hepatology, 24, 289 Tong, 1994, J Gastroenterol Hepatol, 9, 587, 10.1111/j.1440-1746.1994.tb01566.x Stuyver, 1993, J Gen Virol, 74, 1093, 10.1099/0022-1317-74-6-1093 NCSS 97 User Guide. Number Cruncher Statistical Systems. Kaysville, Utah 1997;. Shindo, 1992, Hepatology, 15, 1013, 10.1002/hep.1840150607 Marcellin, 1997, Ann Intern Med, 127, 875, 10.7326/0003-4819-127-10-199711150-00003 Poynard, 1995, N Engl J Med, 332, 1457, 10.1056/NEJM199506013322201 Shiffman, 1999, Gastroenterology, 117, 1164, 10.1016/S0016-5085(99)70402-6 Poynard, 2000, Hepatology, 31, 211, 10.1002/hep.510310131 Degos, 1998, J Hepatol, 29, 224, 10.1016/S0168-8278(98)80007-X